Health Medical Psychedelics News

Microdosing Psychedelics: A New Approach to Managing ADHD Symptoms

Microdosing Psychedelics For Managing ADHD Symptoms
Written by PsychePen

What are the potential long-term effects of microdosing psychedelics on mental health?

Summary: A recent study by the Department of Neuropsychology and Psychopharmacology at Maastricht University in the Netherlands has revealed that microdosing psychedelics, such as magic mushrooms or LSD, could be beneficial for individuals with ADHD. The study found significant improvements in mindfulness and personality traits among participants.

Exploring the Benefits of Microdosing Psychedelics for ADHD Management

The innovative research from Maastricht University has shed light on the potential benefits of microdosing psychedelics for people with ADHD. This condition, often characterized by issues with focus, stress management, and restlessness, affects a significant portion of the adult population.

The study involved nearly 250 participants who engaged in a four-week regimen of microdosing non-hallucinogenic psychedelics. Over 80% of these participants reported practicing mindfulness, a key factor in managing ADHD symptoms. The research measured changes in mindfulness and personality traits throughout the study period.

Remarkably, the results indicated an increase in trait mindfulness, particularly in the aspects of describing and non-judging of inner experiences. Additionally, a decrease in neuroticism was observed after the four weeks of microdosing compared to the baseline. These findings were consistent regardless of whether participants were using conventional medication or had comorbid diagnoses.

In the UK alone, an estimated 2.6 million people are affected by ADHD, according to ADHD UK. This study aligns with previous research published in PLOS One in 2019, which suggested that microdosing psychedelics could reduce depressive symptoms and stress while enhancing focus.

However, the researchers emphasize the need for more thorough follow-up research to confirm these findings, highlighting the preliminary nature of the current study.

Why It Matters: This study opens new avenues for treating ADHD, a condition that affects millions worldwide. The potential of microdosing psychedelics to enhance mindfulness and alter personality traits positively could revolutionize the approach to ADHD management, offering a complementary or alternative option to conventional medications.

Potential Implications: If these findings are confirmed through further research, microdosing psychedelics could become a mainstream treatment option for ADHD. This could lead to a broader acceptance and integration of psychedelic substances in therapeutic settings, potentially benefiting a wide range of individuals who struggle with ADHD and related symptoms.

Source: Mixmag

Subscribe to our weekly newsletter:

We hope you enjoyed this news update. Check back with us daily to see what’s going on in the world of cannabis and psychedelics. And make sure to subscribe to our weekly newsletter, the Cannadelics Sunday Edition with a the best stories of the week:



AI Disclaimer: This news update was created using a AI tools. PsychePen is an AI author who is constantly improving. We appreciate your kindness and understanding as PsychePen continues to learn and develop. Please note that the provided information is derived from various sources and should not be considered as legal, financial, or medical advice.

Have anything to add? Your voice matters! Join the conversation and contribute your insights and ideas below.

This site uses Akismet to reduce spam. Learn how your comment data is processed.

About the author


PsychePen is Cannadelics' main news editor. As a self-taught wellness expert with a unique perspective on drugs, cannabis, and psychedelics, PsychePen is known for his unique style: short and informative articles, easy-to-read and to-the-point. PsychePen is also one of our most successful AI authors. so its keep on improving.